Medco Health Solutions, Inc. (NYSE:MHS)
Provides sophisticated traditional and specialty prescription drug benefit programs and services for clients, members of client-funded benefit plans and individual patients.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
solid player with low PE
Recs
good value whether the xprs acq goes thru or not at this price.
$64 (alone) or $71 (with acq).
Recs
negative news on potential merger
Recs
buyout target, which will fail
Recs
I Bought this stock in Jan 'io . It has gone down and up to where I bought it and down and up. I bought at the top and it still hasn't made any money. It looks like it goes down every year about august or oct. I am readuy to sell if it comes close to what I paid for it ($64.84). I could keep it on my watch list and buy it when it goes down.
Recs
Positive free cash flow of nearly $447 million average per quarter in the last year - good enough for me.
Recs
FCF is outpacing NI, CROIC / ROIC in the double digits (16 & 18% respectively by my calculations), DSO is stable with solid revenue and earnings growth. Priced right at $55.56.
Recs
ppt + research + merger
Recs
Medco supplies mail order drugs for companies health plans. They are well positioned to take advantage on a National Health Plan but will do well if it is not implemented also. Ever increasing numbers of senior citizens are going to need ever increasing prescription drugs.
Recs
simply using it and the M+A to aquire ESRX at a discount.
Recs
Bound to rise once healthcare plan takes off.
Recs
My employer uses this service for perscriptions, and I imagine other large companies do as well. People are getting older and we are a pill popping culture.
Recs
Here's the buy rec:
http://www.fool.com/investing/general/2011/04/19/rising-star-buy-medco-health.aspx
Recs
two sets of two words: "Baby Boomers" and "Old now"
If MHS sold diapers, big cars and Fresca, it would be my largest and only holding.
Recs
near trough PE ratio of ~11 on '12 estimates.
Predictable earnings stream. History of growth in a flat market over past decade+.
Recs
This company fully benefits from the generic drug fiasco. Not going anywhere, even in bad times.
Recs
It's growing and has generics. The healthcare bill should help boost it.
Recs
aging population, key drugs going generic over the next year ... will drive margins and profit for MHS
Recs
This company has been around for a long time with a successful track record in health care. The company has some new products to hit the market in next 12 months that will be in high demand by consumers.
Recs
A ton of baby boomers in need of generics and a ton of patents up in the next few years. Medco is a well run company.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 149 : 1 2 3 4 5 6 7 8 Next »